Amalgamated Financial’s Nu Skin NUS Stock Holding History

Amalgamated Financial’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.56M	Buy	+32,644	New	+$1.62M	0.01%	1000

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Amalgamated Financial's NUS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Nu Skin (NUS) in Q1 2022: 32,644 shares worth $1.56M. The stake represents 0.01% of the portfolio and ranks #1000 among its holdings.

239 funds tracked by Wall St. Rank hold NUS as of Q1 2022.

Amalgamated Financial held 32,644 shares of Nu Skin worth $1.56M as of Q1 2022.
Nu Skin was a new Amalgamated Financial position in Q1 2022.
Nu Skin made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1000 holding.
239 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.